Cyclophosphamide Archives - Medical Conferences

Is allogeneic stem cell transplantation a solid option in R/R LBCL or R/R T-cell lymphoma?

Presented By

Prof. Bertram Glass, Helios Klinikum Berlin-Buch, Germany

Trial

Phase 2, ASTRAL

Conference

ASH 2023

Type

Peer-reviewed article

7 February 2024 15:00

Thalassaemia: Advances in conventional transplantation and gene therapy

Presented By

Prof. Josu de la Fuente, Imperial College London, UK

Conference

EBMT 2023

Type

Peer-reviewed article

15 June 2023 17:06

Tacrolimus versus cyclosporin A in AML

Presented By

Dr Gesine Bug, Goethe University Frankfurt, Germany

Conference

EBMT 2023

Type

Peer-reviewed article

14 June 2023 19:48

Novel therapy may replace standard-of-care prophylaxis for GVHD

Presented By

Prof. Shernan Holtan, University of Minnesota, MN, USA

Trial

Phase 3, BMT CTN 1703

Conference

ASH 2022

Type

Peer-reviewed article

20 February 2023 13:05

Ifosfamide is likely to be the go-to therapy in recurrent Ewing sarcoma

Presented By

Dr Martin McCabe, University of Manchester, UK

Trial

Phase 3, rEECur

Conference

ASCO 2022

Type

Peer-reviewed article

5 August 2022 15:32

Is avacopan better than prednisone for respiratory ANCA-associated vasculitis outcomes?

Presented By

Prof. Ulrich Specks, Mayo Clinic, MN, USA

Trial

Phase 3, ADVOCATE

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 11:56

POLARIX: Novel regimen superior to R-CHOP in DLBCL

Presented By

Prof. Hervé Tilly, University of Rouen, France

Trial

Phase 3, POLARIX

Conference

ASH 2021

Type

Peer-reviewed article

4 February 2022 10:56

Concurrent taxane plus anthracycline most beneficial in reducing risk of breast cancer

Presented By

Dr Jeremy Braybrooke, University Hospitals Bristol NHS Foundation Trust, UK

Conference

SABCS 2021

Type

Peer-reviewed article

31 January 2022 16:44

ASH 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ASH 2021

4 January 2022 08:00

ANDROMEDA: Addition of daratumumab showed superior efficacy in patients with AL amyloidosis

Presented By

Prof. Efstathios Kastritis, National and Kapodistrian University of Athens, Greece

Trial

Phase 3, ANDROMEDA

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 14:31

Fixed 12 cycles and MRD-guided venetoclax consolidation effective in CLL

Presented By

Dr Mark-David Levin, Albert Schweitzer Hospital, the Netherlands

Trial

Phase 2, HOVON 139/GiVe

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 13:38

Lupus nephritis: new therapies on the horizon in 2020

Presented By

Prof. Joan T. Merrill, Oklahoma Medical Research Foundation, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:54

Daratumumab for light-chain amyloidosis

Presented By

Dr Efstathios Kastritis, National and Kapodistrian University of Athens, Greece

Trial

Phase 3, ANDROMEDA

Conference

EHA 2020

Type

Peer-reviewed article

9 September 2020 10:49

HOVON-96: Better outcomes with cyclophosphamide after transplantation

Presented By

Dr Annoek Broers, Erasmus MC Cancer Institute, the Netherlands

Conference

ASH 2019

Type

Peer-reviewed article

5 March 2020 23:53

High rates of ROR-low disease with chemotherapy-free regimen in HR+/HER2- patients

Trial

Phase 2, CORALLEEN

Conference

SABCS 2019

Type

Peer-reviewed article

13 February 2020 23:05

No added benefit for doxorubicin + docetaxel vs doxorubicin + cyclophosphamide

Conference

SABCS 2019

Type

Peer-reviewed article

13 February 2020 12:51

Subcutaneous daratumumab + cyclophosphamide, bortezomib, and dexamethasone in patients with newly diagnosed amyloid light chain amyloidosis

Presented By

Prof. Raymond Comenzo, Tufts University, USA

Trial

Phase 3, ANDROMEDA

Conference

EHA 2019

Type

Peer-reviewed article

9 August 2019 19:40